Development of an Efficient and Scalable Asymmetric Synthesis of Eliglustat via Ruthenium(II)-Catalyzed Asymmetric Transfer Hydrogenation

被引:17
作者
Sun, Guodong [1 ,2 ]
Jian, Weilin [3 ]
Luo, Zhonghua [3 ]
Sun, Tengfei [3 ]
Li, Chao [3 ]
Zhang, Jiancun [1 ]
Wang, Zhongqing [3 ,4 ]
机构
[1] Chinese Acad Sci, Guangzhou Inst Biomed & Heath, 190 Kaiyuan Rd, Guangzhou 510530, Guangdong, Peoples R China
[2] Univ Chinese Acad Sci, 19 Yuquan Rd, Beijing 100049, Peoples R China
[3] HEC Res & Dev Ctr, HEC Pharm Grp, Dongguan 523871, Peoples R China
[4] HEC Pharma Grp, New Drug Res Inst, Antiinfect Innovat Dept, Dong Guan 523871, Peoples R China
关键词
eliglustat; asymmetric synthesis; ruthenium catalyst; asymmetric transfer hydrogenation; dynamic kinetic resolution; DYNAMIC KINETIC RESOLUTION;
D O I
10.1021/acs.oprd.9b00138
中图分类号
O69 [应用化学];
学科分类号
081704 ;
摘要
An efficient and scalable synthesis of eliglustat (1) is herein reported. This novel route features a three-step telescoped process to afford the alpha-dibenzylamino beta-ketoester 6 in 85% overall yield from commercially available 1,4-benzodioxane-6-carboxylic acid 7. The key intermediate 5 was obtained via an efficient ruthenium-catalyzed DKR-ATH reaction, which afforded the desired product in 90% isolated yield with >99:1 dr and 99.7% ee on a 100 g scale. In addition, the amidation of sterically hindered carboxylic acid 14 was optimized and amenable to scale-up. This process not only gives a desirable total yield but also avoids hazardous conditions and chromatographic purification. The robustness of this synthesis was successfully performed on a multigram scale to afford 1 with >99.9% de and >99.9% ee in 56.8% overall yield in nine steps.
引用
收藏
页码:1204 / 1212
页数:9
相关论文
共 26 条
  • [1] Multi-Kilo Delivery of AMG 925 Featuring a Buchwald-Hartwig Amination and Processing with Insoluble Synthetic Intermediates
    Affouard, Caroline
    Crockett, Richard D.
    Diker, Khalid
    Farrell, Robert P.
    Gorins, Gilles
    Huckins, John R.
    Caille, Seb
    [J]. ORGANIC PROCESS RESEARCH & DEVELOPMENT, 2015, 19 (03) : 476 - 485
  • [2] Choosing the Right Coupling Reagent for Peptides: A Twenty-Five-Year Journey
    Albericio, Fernando
    El-Faham, Ayman
    [J]. ORGANIC PROCESS RESEARCH & DEVELOPMENT, 2018, 22 (07) : 760 - 772
  • [3] Eliglustat tartrate for the treatment of adults with type 1 Gaucher disease (vol 9, pg 4639, 2015)
    Bennett, L. L.
    Turcotte, K.
    [J]. DRUG DESIGN DEVELOPMENT AND THERAPY, 2015, 9
  • [4] TCFH-NMI: Direct Access to N-Acyl Imidazoliums for Challenging Amide Bond Formations
    Beutner, Gregory L.
    Young, Ian S.
    Davies, Merrill L.
    Hickey, Matthew R.
    Park, Hyunsoo
    Stevens, Jason M.
    Ye, Qingmei
    [J]. ORGANIC LETTERS, 2018, 20 (14) : 4218 - 4222
  • [5] Evolution of a Manufacturing Route to Omarigliptin, A Long-Acting DPP-4 Inhibitor for the Treatment of Type 2 Diabetes
    Chung, John Y. L.
    Scott, Jeremy P.
    Anderson, Camille
    Bishop, Brian
    Bremeyer, Nadine
    Cao, Yang
    Chen, Qmghao
    Dunn, Robert
    Kassim, Amude
    Lieberman, David
    Moment, Aaron J.
    Sheen, Faye
    Zacuto, Michael
    [J]. ORGANIC PROCESS RESEARCH & DEVELOPMENT, 2015, 19 (11) : 1760 - 1768
  • [6] Stereoarrayed 2,3-Disubstituted 1-Indanols via Ruthenium(II)-Catalyzed Dynamic Kinetic Resolution-Asymmetric Transfer Hydrogenation
    Cotman, Andrei Emanuel
    Modec, Barbara
    Mohar, Barbara
    [J]. ORGANIC LETTERS, 2018, 20 (10) : 2921 - 2924
  • [7] Large-Scale Applications of Amide Coupling Reagents for the Synthesis of Pharmaceuticals
    Dunetz, Joshua R.
    Magano, Javier
    Weisenburger, Gerald A.
    [J]. ORGANIC PROCESS RESEARCH & DEVELOPMENT, 2016, 20 (02) : 140 - 177
  • [8] DIBENZYLAMINOACETATES AS USEFUL SYNTHETIC EQUIVALENTS OF GLYCINE IN THE SYNTHESIS OF ALPHA-AMINO-BETA-HYDROXYACIDS
    GUANTI, G
    BANFI, L
    NARISANO, E
    SCOLASTICO, C
    [J]. TETRAHEDRON, 1988, 44 (12) : 3671 - 3684
  • [9] Practical Diastereoselective Synthesis and Scale-up Study of (+)-2-((1R,2R,3R,5S)-2-Amino-6,6-dimethylbicyclo[3.1.1]hept-3-yl)ethanol: A Key Intermediate of the Novel Prostaglandin D2 Receptor Antagonist S-5751
    Hida, Takemasa
    Mitsumori, Susumu
    Honma, Tsunetoshi
    Hiramatsu, Yoshiharu
    Hashizume, Hiroshi
    Okada, Tetsuo
    Kakinuma, Makoto
    Kawata, Kyozo
    Oda, Katsuo
    Hasegawa, Aiko
    Masui, Toshiaki
    Nogusa, Hideo
    [J]. ORGANIC PROCESS RESEARCH & DEVELOPMENT, 2009, 13 (06) : 1413 - 1418
  • [10] Inokuchi J. I., 2017, Patent Appl, Patent No. [W02017204319 1, 20172043191]